Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 2
2008 9
2009 6
2010 13
2011 8
2012 5
2013 5
2014 6
2015 5
2016 5
2017 6
2018 1
2019 9
2020 10
2021 15
2022 8
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Monoclonal antibody therapies against SARS-CoV-2.
Focosi D, McConnell S, Casadevall A, Cappello E, Valdiserra G, Tuccori M. Focosi D, et al. Among authors: tuccori m. Lancet Infect Dis. 2022 Nov;22(11):e311-e326. doi: 10.1016/S1473-3099(22)00311-5. Epub 2022 Jul 5. Lancet Infect Dis. 2022. PMID: 35803289 Free PMC article. Review.
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety.
Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, Ferrajolo C, Moretti U, Poluzzi E, Raschi E, Ravaldi C, Reno C, Tuccori M, Vannacci A, Zanoni G, Trifirò G; Ilmiovaccino COVID19 collaborating group. Luxi N, et al. Among authors: tuccori m. Drug Saf. 2021 Dec;44(12):1247-1269. doi: 10.1007/s40264-021-01131-6. Epub 2021 Nov 5. Drug Saf. 2021. PMID: 34739716 Free PMC article. Review.
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials.
Ahmadizar F, Luxi N, Raethke M, Schmikli S, Riefolo F, Saraswati PW, Bucsa C, Osman A, Liddiard M, Maques FB, Petrelli G, Sonderlichová S, Thurin NH, Villalobos F, Trifirò G, Sturkenboom M; ilmiovaccinoCOVID19 collaborating group. Ahmadizar F, et al. Drug Saf. 2023 Jun;46(6):575-585. doi: 10.1007/s40264-023-01304-5. Epub 2023 Apr 27. Drug Saf. 2023. PMID: 37103643 Free PMC article.
Progressive multifocal leukoencephalopathy: what's new?
Focosi D, Marco T, Kast RE, Maggi F, Ceccherini-Nelli L, Petrini M. Focosi D, et al. Among authors: marco t. Neuroscientist. 2010 Jun;16(3):308-23. doi: 10.1177/1073858409356594. Neuroscientist. 2010. PMID: 20479473 Review.
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis.
Raschi E, Salvo F, Bate A, De Ponti F, Poluzzi E, Tuccori M, van Puijenbroek E, Joshi N, Khouri C. Raschi E, et al. Among authors: tuccori m. Drug Saf. 2024 Mar 18. doi: 10.1007/s40264-024-01419-3. Online ahead of print. Drug Saf. 2024. PMID: 38498258 No abstract available.
Convalescent Plasma Therapy for COVID-19: State of the Art.
Focosi D, Anderson AO, Tang JW, Tuccori M. Focosi D, et al. Among authors: tuccori m. Clin Microbiol Rev. 2020 Aug 12;33(4):e00072-20. doi: 10.1128/CMR.00072-20. Print 2020 Sep 16. Clin Microbiol Rev. 2020. PMID: 32792417 Free PMC article. Review.
115 results